Your body uses the DLL1 gene to send signals that guide early development, especially in the brain, spine, and other growing tissues. This gene plays an important role in helping cells decide when to divide, specialize, or stop. If a harmful variant disrupts this signaling, a person may have developmental delay, learning difficulties, seizures, or differences in the spine and ribs. Effects vary widely, and some people are only mildly affected.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or manage processes throughout the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Other genes mainly regulate when and where certain processes take place, and how active those processes are. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
DLL1Gene function
What if the gene works
The DLL1 gene helps neighboring cells send signals that guide how cells develop and specialize. This is especially important during early development, including formation of the spine, brain, and other tissues.
Risk
What if the gene does not work
Variants in the DLL1 gene can affect early brain and spine development, often causing developmental delay, learning difficulties, seizures, and spine or rib differences. Milder and more severe variants can change when symptoms begin and how much they affect you.
Treatment
What does that mean for your treatment
No treatment or management approach specific to a pathogenic variant in the DLL1 gene is currently established. The DLL1 gene is being studied through the Notch signaling pathway as a possible biomarker or drug target in some cancers, but this has not led to gene directed care for DLL1 related conditions.
Conditions associated with DLL1
Gene function
What if the gene works
Your cells use signals from the DLL1 gene to communicate with nearby cells at just the right time. These messages are especially important during early growth, when tissues are taking shape. This helps explain what the DLL1 gene does in the body as cells choose roles and build organized structures.
The DLL1 gene makes a surface signal that nearby cells can read through the Notch pathway (a cell to cell signaling system). This message works when cells touch and helps them coordinate their next steps.
During development, DLL1 signaling helps cells decide whether to stay in a more flexible state or start becoming a specialized cell. This careful timing supports orderly growth in places such as the brain, spine, and other forming tissues.
DLL1 helps organize repeating structures in the early embryo, including the segments that later contribute to the spine and ribs. This steady patterning is part of how the body plan forms in the right order.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal human variation, including differences in appearance, metabolism, and the way the body reacts to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic diversity. In some cases, though, a variant changes how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the DLL1 gene can reduce how much DLL1 protein reaches the cell surface or change its shape, making it less able to trigger Notch signaling. Some variants create a shortened protein that is quickly broken down, while others leave a partly working protein. This range helps explain how DLL1 gene variants affect cell signaling, from milder changes with partial activity to more severe variants that markedly lower signaling. More disruptive variants may be linked to earlier neurodevelopmental changes.
How variants are linked to conditions
Pathogenic variants in the DLL1 gene cause a DLL1-related neurodevelopmental condition. In studies and clinical practice, variants in the DLL1 gene are linked to developmental delay, learning difficulties or intellectual disability, autism features, seizures, and brain imaging changes. Some people also have spine or rib differences, including scoliosis. Features can vary widely from one person to another, even within the same family.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not have a direct impact on health and simply reflect natural variation among people. For many genes, carrying a variant connected with a condition indicates a possible association rather than a certain diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that increase or reduce health risks related to the DLL1 gene. If a disease-causing DLL1 variant is present in a family, the main factor shaping risk is whether that variant was inherited or happened new in the child.
Inheritance of DLL1 variants
DLL1-related conditions are inherited in an autosomal dominant pattern, which means one altered copy of the DLL1 gene can be enough to cause the condition. If a parent carries a disease-causing variant in the DLL1 gene, each child has a 50% chance of inheriting it. Some people have a new, de novo variant in the DLL1 gene that was not inherited from either parent. In practical terms, how variants of the DLL1 gene are inherited depends on whether the variant was passed down in a family or arose for the first time in that person.
What does my DLL1 result mean for my family?
For DLL1, the best-established family pattern is dominant, so a parent, child, brother, or sister may also carry the same gene change and could consider genetic counseling or testing. If a parent carries it, each child has a 1 in 2, or 50%, chance of inheriting it. Some DLL1 changes happen for the first time in one person, so a parent does not always have the same result.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for DLL1 variants usually uses a blood sample or cheek swab. A lab reads the DLL1 gene and checks whether a variant may help explain developmental findings or support family testing. Results from DLL1 genetic testing may show a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Testing for changes in the DLL1 gene may be considered when a child has unexplained developmental or speech delay, low muscle tone, seizures, or a curved spine, especially if a brain scan also shows unusual findings. It can also be worth discussing if similar features run in the family.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they reveal depends on the condition and on the kind of variant found. Over time, the way your body functions is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is most useful when considered with the rest of a person’s care. In other situations, a genetic result can give a clear answer. For medication response, it can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same drug may work well for one person, have less effect in another, or cause more side effects in someone else. One reason is that inherited differences can change how the body breaks down, transports, or responds to a medication. These differences are common and can influence both how well a treatment works and how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics is the study of how differences in genes can shape the way someone responds to medication. By looking at relationships between genes and drugs, it helps explain why the same treatment may work differently from one person to another. In the case of many medicines, genes can influence how strong a drug’s effects are or how the body processes that drug. This information can help guide treatment decisions that are more informed and more individualized. To explore the subject further, more information is available in the LearnHub.
Drugs influenced by the DLL1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used. For questions about symptoms, treatment, side effects, or any medication changes, talk with your doctor.
History
DLL1 entered human genetics through broader work on the Notch signaling pathway, which had first been mapped in fruit flies before matching genes were identified in mammals. In the 1990s, researchers recognized the DLL1 gene as a human relative of the Delta gene, linking decades of developmental biology to human genetics. Building on this early work, scientists connected DLL1 to vertebrate embryo development, especially studies of how the spine and body segments form. As genetic testing improved, variants in the DLL1 gene were later reported in people with developmental differences, which brought the gene into clinical practice. Over time, descriptions became more precise, moving DLL1 from a research gene to one used in diagnosis and counseling.